PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 54 filers reported holding PEAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $127,591 | -78.4% | 500,356 | 0.0% | 0.02% | -77.1% |
| Q4 2022 | $590,420 | -42.2% | 500,356 | 0.0% | 0.07% | -39.1% |
| Q3 2022 | $1,021,000 | +32.4% | 500,356 | 0.0% | 0.12% | +47.4% |
| Q2 2022 | $771,000 | -69.5% | 500,356 | 0.0% | 0.08% | -67.4% |
| Q1 2022 | $2,527,000 | -18.5% | 500,356 | 0.0% | 0.24% | -11.2% |
| Q4 2021 | $3,102,000 | – | 500,356 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arboretum Ventures, Inc. | 10,859,050 | $67,326,000 | 38.78% |
| 5AM Venture Management, LLC | 18,631,771 | $115,517,000 | 21.68% |
| TB Alternative Assets Ltd. | 2,071,865 | $12,846,000 | 3.80% |
| Palantir Technologies Inc. | 1,000,000 | $6,200,000 | 2.81% |
| SB Global Advisers Ltd | 12,100,078 | $75,020,000 | 1.49% |
| EDBI Pte Ltd | 426,371 | $2,644,000 | 1.44% |
| Temasek Holdings (Private) Ltd | 26,803,573 | $166,182,000 | 0.60% |
| Alpine Global Management, LLC | 625,134 | $3,876,000 | 0.57% |
| Blue Water Life Science Advisors, LP | 194,686 | $1,207,000 | 0.37% |
| Sarissa Capital Management LP | 500,356 | $3,102,000 | 0.27% |